首页> 外文OA文献 >Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)

【2h】

Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)

机译：降压是否是预防中风的有效替代指标？一项分析包括对随机对照试验的系统评价，试验加权加权变量误差回归，替代阈值效应（STE）和生物标志物替代（BioSurrogate）评估方案（BSES）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Marissa N Lassere; Kent R Johnson; Michal Schiff; David Rees;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES) [J] . Marissa N Lassere, Kent R Johnson, Michal Schiff, BMC Medical Research Methodology . 2012,第1期

机译：降低血压是否是预防中风的有效替代指标？一项分析包括对随机对照试验的系统评价，按试验进行的加权变量误差回归，替代阈值效应（STE）和生物标志物替代（BioSurrogate）评估方案（BSES）
2. Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials [J] . Suh Chong Hyun, Kim Ho Sung, Jung Seung Chai, Korean journal of radiology : . 2020,第4期

机译：胶质母细胞瘤的有针对性疗法的优化的基于图像的代理终点：系统评价和阶段分析III期随机对照试验
3. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): Incorporating a systematic review, metaanalysis and value of information analysis [J] . Health technology assessment: HTA . 2012,第7期

机译：评估败血症（严重脓毒症和败血性休克）静脉免疫球蛋白的多中心随机对照试验的信息的可行性，成本和价值：纳入系统的综述，荟萃分析和信息分析的价值
4. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials a by-trial weighted errors-in-variables regression the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES) [O] . Marissa N Lassere, Kent R Johnson, Michal Schiff, 2012

机译：降压是否是预防中风的有效替代指标？一项分析包括对随机对照试验的系统评价试验加权加权变量误差回归替代阈值效应（STE）和生物标志物替代（BioSurrogate）评估方案（BSES）
5. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES) [O] . Lassere, Marissa N, Johnson, Kent R, Schiff, Michal, 2012

机译：降压是否是预防中风的有效替代指标？一项分析包括对随机对照试验的系统评价，试验加权加权变量误差回归，替代阈值效应（STE）和生物标志物替代（BioSurrogate）评估方案（BSES）

著录项

相似文献

相关主题

期刊订阅